Elvia Cowan, SVP, FINANCE at Vaxcyte, Inc. (PCVX), sold 5,000 shares at $85.00 ($425K) on 2024-07-16, disclosed to the SEC on 2024-07-17.
Scheduled sale ($425k) by SVP, FINANCE under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PCVX | SELL | 2026-03-18 | $210K | — | Filing → |
| PCVX | SELL | 2026-03-11 | $293K | — | Filing → |
| PCVX | SELL | 2025-12-29 | $1.1M | — | Filing → |